Israel Englander Arcutis Biotherapeutics, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 512,696 shares of ARQT stock, worth $4.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

512,696

Previous 379,051 35.26%

Holding current value

$4.95 Million

Previous $3.76 Million 26.94%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $967,589 - $1.67 Million	133,645 Added 35.26%	512,696 $4.77 Million
Q1 2024 May 15, 2024	SELL	$3.25 - $11.77 $7.08 Million - $25.7 Million	-2,179,829 Reduced 85.19%	379,051 $3.76 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $4.71 Million - $12.3 Million	2,558,880 New	2,558,880 $8.27 Million
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $8.08 Million - $11.8 Million	578,550 Added 673.54%	664,447 $9.83 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $1.53 Million - $2.31 Million	85,897 New	85,897 $1.64 Million
Q2 2022 Aug 15, 2022	SELL	$16.33 - $22.2 $1.64 Million - $2.22 Million	-100,126 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.38 - $22.79 $1.44 Million - $2.28 Million	100,126 New	100,126 $1.93 Million
Q4 2021 Feb 14, 2022	SELL	$14.98 - $25.5 $458,657 - $780,759	-30,618 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $590,315 - $829,747	30,618 New	30,618 $731,000
Q2 2021 Aug 16, 2021	SELL	$24.42 - $34.75 $368,571 - $524,481	-15,093 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$24.47 - $36.98 $3.55 Million - $5.36 Million	-145,001 Reduced 90.57%	15,093 $437,000
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $2.31 Million - $4.11 Million	129,452 Added 422.47%	160,094 $4.5 Million
Q3 2020 Nov 16, 2020	BUY	$23.44 - $32.28 $110,238 - $151,812	4,703 Added 18.13%	30,642 $898,000
Q2 2020 Aug 14, 2020	BUY	$24.48 - $36.56 $344,066 - $513,850	14,055 Added 118.27%	25,939 $784,000
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $219,854 - $438,519	11,884 New	11,884 $354,000

Others Institutions Holding ARQT

# of Institutions

194

Shares Held

128M

Call Options Held

5.43M

Put Options Held

257K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $581M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account